Stocks
Intercept Pharmaceuticals (ICPT) EBITDA margin US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -155.0% | -120.5% | -67.9% | -14.7% | -21.6% | -13.1% | ||
| Changes by years, y/y, % | +94pp | +35pp | +53pp | +53pp | -7pp | -38.7% | |||
Intercept Pharmaceuticals. EBITDA margin, %
Intercept Pharmaceuticals. EBITDA margin, changes, pp
Intercept Pharmaceuticals (ICPT) EBITDA margin US GAAP (quarter values) |
||||||||
| 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | LTM ? | |||
| EBITDA margin, % | ? | -9.86% | -19.1% | -42.8% | -3.60% | 5.80% | -13.1% | |
| Changes by years, y/y, % | -21pp | +118pp | -31pp | +16pp | +16pp | |||
| Changes by quarters, q/q, % | +10pp | -9pp | -24pp | +39pp | +9pp | |||
